Home›Stock Screener›NGL Fine Chem

NGL Fine Chem Share Price Today | Stock Price & NGL Fine Chem Share Screener

NGLFINE Pharmaceuticals & Biotechnology
Live Share Price NSE
₹2848.50
▲ 4.30 (0.15%)
2026-11-18 00:00:00
Live Share Price BSE
₹2854.45
▼ -5.50 (-0.19%)
2026-11-18 00:00:00

As of November 18, 2026, the live NGL Fine Chem share price (NSE: NGLFINE) is ₹2,848.50 on NSE and ₹2,854.45 on BSE, up 0.15% from the previous close, with shares trading between ₹2,811.00 and ₹2,871.80 in today's trading session, and a 52-week range of ₹1,278.80–₹3,457.80. Track NGLFINE market cap trends to gauge the company's total market size. Use the NGL Fine Chem stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today NGL Fine Chem opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹160 and net income of ₹16, with EBITDA of ₹29, an operating margin of 18.0% and a profit margin of 10.0%.

NGL Fine Chem Market Cap ₹1,878.90 Cr.
NGLFINE P/E Ratio (TTM) 29.40
NGL Fine Chem P/B Ratio 5.18
EPS (TTM) ₹77.90
Dividend Yield 0.06%
Debt to Equity 0.33
NGLFINE 52 Week High ₹3457.80
NGL Fine Chem 52 Week Low ₹1278.80
Operating Margin 18.00%
Profit Margin 10.00%
NGLFINE Revenue (TTM) ₹160.00
EBITDA ₹29.00
Net Income ₹16.00
Total Assets ₹546.00
Total Equity ₹329.00

NGL Fine Chem Share Price Chart

Track the current stock price of NGL Fine Chem with an interactive chart. Analyse NGLFINE share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete NGL Fine Chem stock quote in one place.

The quote of ₹2,848.50 sits between the 52-week low of ₹1,278.80 and the 52-week high of ₹3,457.80, and the latest session moved 0.15% from the previous close.

NGL Fine Chem Company Profile - Fundamental Screener

Screen NGL Fine Chem company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for NGLFINE shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals & Biotechnology industry, and it trades under ISIN INE887E01022.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals & Biotechnology
Sub-Sector Pharmaceuticals & Biotechnology
Segment E

Identifiers and Leadership

ISIN INE887E01022

NGL Fine Chem Balance Sheet Screener

Screen NGLFINE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹546, up from ₹435 in 2025.

Latest statistics put total assets at ₹546 and shareholder funds at ₹329, with a leverage ratio of 0.33.

Item 2026 2025 2024 2023 2022 2021 2020 2019

Assets

Total Assets 546 435 356 287 277 207 154 142
Current Assets 0 0 0 0 0 0 0 0
Fixed Assets 164 143 86 88 89 64 68 61

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0
Current Liabilities 66 34 6 6 8 11 12 12
Non-Current Liabilities 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 329 282 263 223 203 155 99 92
Share Capital 3 3 3 3 3 3 3 3
Reserves & Surplus 326 279 260 220 200 151 96 89

NGL Fine Chem Income Statement Screener - Profit & Revenue Analysis

Screen NGL Fine Chem income statement and profit fundamentals. Analyze NGLFINE quarterly results. NGL Fine Chem reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Sept, revenue was ₹160 and net profit was ₹16, equal to earnings per unit of ₹26.30, at an operating margin of 18%.

In that period expenses were ₹131, interest cost ₹1 and tax ₹5. The next period listed, 2026-Jun, shows revenue of ₹147 and net profit of ₹18.

Item 2026-Sept 2026-Jun 2026-Mar 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec

Revenue and Expenses

Revenue 160 147 152 94 111 122 132 103 97 99 89 76 74 83 92
Expenses 131 116 128 89 93 103 105 84 81 82 84 61 61 66 74

Operating Costs and Margins

EBITDA 29 31 24 5 17 19 27 20 15 17 5 15 13 17 18
Operating Profit % 18.00% 17.00% 14.00% 7.00% 11.00% 14.00% 18.00% 16.00% 10.00% 12.00% 6.00% 19.00% 14.00% 17.00% 16.00%
Depreciation 7 5 5 3 4 5 5 3 3 3 3 3 3 3 3
Interest 1 1 1 1 1 1 1 1 0 0 1 0 0 0 0

Profit and Earnings

Profit Before Tax 22 25 18 1 12 13 21 16 12 13 1 12 10 14 14
Tax 5 6 4 1 3 3 5 4 3 4 0 3 2 4 4
Net Profit 16 18 14 1 9 10 16 12 9 10 1 9 9 11 10
EPS 26.30 29.78 21.83 0.88 14.96 15.58 25.40 19.95 14.92 15.88 2.07 15.09 13.77 16.96 16.24

NGL Fine Chem Cash Flow Screener - Liquidity Fundamentals

Screen NGLFINE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹43, and net cash flow was an inflow of ₹2.

Over the same period, investing activities used ₹71 and financing activities provided ₹30.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March

Cash from Operations and Investing

Operating Activities 43 32 21 35 14 27 21 9
Investing Activities -71 -70 -27 -27 -14 -25 -20 -10

Financing and Net Cash

Financing Activities 30 38 -1 -1 -1 -1 -1 0
Net Cash Flow 2 0 -7 7 -2 2 0 -1

NGL Fine Chem Shareholding Pattern Screener

See NGL Fine Chem shareholding pattern with promoter, FII, and DII holdings. Check NGL Fine Chem promoter holding and ownership changes for NGLFINE on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Sept, promoters held 72.49%, foreign institutions 0.04%, domestic institutions 0.00% and the public 22.59%, spread across 12,939 shareholders.

The shareholder count was 12,939 in 2026-Sept, compared with 13,393 in 2026-Jun.

Item 2026-Sept 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec

Promoter Holding

Promoter Holding 72.49% 72.49% 72.74% 72.74% 72.74% 72.74% 72.74% 72.74%

Institutional Investors

FII Holding 0.04% 0.05% 0.03% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.02% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 22.59% 22.63% 22.66% 22.92% 23.01% 23.00% 22.75% 21.70%
Other Holding 4.87% 4.81% 4.57% 4.34% 4.25% 4.27% 4.51% 5.56%
Shareholder Count 12,939 13,393 12,516 12,834 13,387 14,010 14,386 14,110

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by NGL Fine Chem. NGL Fine Chem dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹1.75 per unit for 2026-March, a yield of 0.06%, compared with ₹1.75 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹1.75, ₹1.75 and ₹1.75 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹1.75 0.06%
2025-March ₹1.75 0.09%
2024-March ₹1.75 0.15%
2023-March ₹1.75 0.08%
2022-March ₹1.75 0.14%
2021-March ₹1.75 0.09%
2020-March ₹1.75 0.11%
2019-March ₹1.75 0.69%
2018-March ₹0.00 0.00%
2017-March ₹0.00 0.00%

NGL Fine Chem Stock Index Membership - Nifty & Sensex

See which indices include NGL Fine Chem stock. Check NGLFINE index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 2 indices, including BSE INDEX BSE HC.

Among the benchmarks tracked are BSE INDEX BSE HC, BSE INDEX SMLCAP.

Complete Index List

BSE INDEX BSE HC
BSE INDEX SMLCAP

NGL Fine Chem Market Events Screener - Corporate Actions

Get NGL Fine Chem corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check NGL Fine Chem stock events that may affect NGLFINE share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 6, 2026, with a record date of November 6, 2026.

It is followed by Annual General Meeting dated August 25, 2026 and Dividend dated August 18, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-06 2026-11-06 Quarterly Result Announcement NA 12.38%
2026-08-25 2026-08-25 Annual General Meeting NA 18.54%
2026-08-18 2026-08-18 Dividend ₹ 1.75 /share 21.30%
2026-08-12 2026-08-12 Quarterly Result Announcement NA 0.71%
2026-05-21 2026-05-21 Quarterly Result Announcement NA 2.91%
2026-02-03 2026-02-03 Quarterly Result Announcement NA 22.32%
2025-11-12 2025-11-12 Quarterly Result Announcement NA -3.76%
2025-08-19 2025-08-19 Annual General Meeting NA 6.27%
2025-08-12 2025-08-12 Dividend ₹ 1.75 /share -5.32%
2025-08-01 2025-08-01 Quarterly Result Announcement NA -0.55%
2025-05-22 2025-05-22 Quarterly Result Announcement NA 15.10%
2025-02-07 2025-02-07 Quarterly Result Announcement NA 16.09%
2024-11-08 2024-11-08 Quarterly Result Announcement NA 9.98%
2024-08-23 2024-08-23 Annual General Meeting NA -1.27%
2024-08-16 2024-08-16 Dividend ₹ 1.75 /share -0.27%

NGL Fine Chem Competitors Screener - Peer Stocks Comparison

Screen NGLFINE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 451,075 41.10 61,674 12.69% 11,565 63.60
Divis Laboratories 303,749 90.70 11,067 13.95% 2,568 78.53
Torrent Pharmaceuticals 177,632 84.50 13,886 20.34% 2,138 47.27
Laurus Labs 130,972 98.10 6,868 22.01% 890 69.60
Zydus Life Science 118,693 27.60 27,658 17.64% 5,026 52.34
Dr Reddys Laboratories 115,186 41.70 35,059 3.90% 4,158 70.24
Cipla 112,438 39.40 29,045 2.24% 3,870 54.92
Mankind Pharma 109,044 48.40 14,636 14.85% 1,938 65.43
Aurobindo Pharma 104,903 26.40 34,145 5.56% 3,503 66.06
Lupin 90,557 17.30 29,039 26.75% 5,356 44.92

NGL Fine Chem Company Announcements - News & Reports Screener

Screen NGLFINE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 17, 2026.

The next most recent announcements are dated November 15, 2026 and November 14, 2026.

Date Update Actions
2026-11-17 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome -
2026-11-15 Announcement under Regulation 30 (LODR)-Investor Presentation -
2026-11-14 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-11-14 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-11-11 Disclosure under Regulation 30A of LODR -
2026-11-11 Outcome Of The Board Meeting Dated November 06 2026 -
2026-11-11 Board Meeting Outcome for Outcome Of Board Meeting -
2026-11-10 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-10-31 Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29(1) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-10-13 Intimation Regarding Receipt Of SEBI Exemption Order Under Regulation 11(5) Of The SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011 -
2026-10-05 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-09-28 Closure of Trading Window -
2026-09-25 Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI LODR Regulations) - Show Cause Notice Received From The GST Department -
2026-09-24 Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Commencement Of Commercial Production Of Phase II Of Greenfield Facility At Tarapur. -
2026-09-16 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome -
2026-09-10 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-08-27 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-08-25 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-08-20 Corrigendum To The 45Th Annual Report For The Financial Year 2025-2026 -
2026-08-17 Announcement under Regulation 30 (LODR)-Investor Presentation -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹2,848.50, within a 52-week range of ₹1,278.80 to ₹3,457.80. The P/E ratio is 29.40 and the P/B ratio is 5.18, with earnings per unit of ₹77.90. Market capitalisation stands at ₹1,878.90 Cr and the dividend yield is 0.06%. The company operates in the Healthcare sector, in the Pharmaceuticals & Biotechnology industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on November 20, 2026. This page covers 8 balance sheet periods, 15 income statement periods, 8 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.